|Articles|June 18, 2006
New LabPAS/CT V 2.5, Complete P1 Trial Workflow System with PDA, to be Unveiled at DIA Annual Meeting
Green Mountain Logic will unveil LabPAS/CT Version 2.5 at the DIA Annual Meeting.
Advertisement
Philadelphia, June 18–21, booth # 1520-Version 2.5 deploys PDAs on clinic floors to scan patient and collection vessel barcodes, eliminating the potential for errors. It provides real time electronic data entry for collection times, comments, dosing, vital signs and adverse events. LabPAS/CT 2.5 also allows integration with document management systems and with biometric systems for positive subject ID.
LabPAS/CT uses a Web interface and intuitive navigation and is the most scalable, configurable and customizable workflow and sample management solution on the market today. Through the innovative use of barcode scanning it eliminates errors, tracks samples, increases throughput, and supports compliance. In addition, sample collection and dosing are scheduled and tracked according to trial protocols. LabPAS/CT supports compliance with FDA 21 CFR Part 11, GCP and GLP, and also empowers study managers to rapidly alter workflow and schedules as protocols change, by simply dragging and dropping items on their computer screen. It was developed under Green Mountain Logic's design control process, audited and approved by multiple, nationally-recognized pharmaceutical clients. GML is in compliance with FDA guidance for the development of high-risk software systems and for development of Class 2 Medical Devices.
Articles in this issue
about 19 years ago
Article
Phase Forward Delivers Enhanced Integration Capabilities as Part of Ongoing Adapter Strategyabout 19 years ago
Article
ClinPhone Exhibits its Clinical Trial Technology Solutions at 42nd DIA Annual Meetingabout 19 years ago
Article
Omnicomm Systems Inc., Introduces New TrialMaster V.4.0 at DIA's 42nd Annual MeetingNewsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Advertisement
Related Articles
- Q&A: Strategies for Successful Global Clinical Trial Delivery
September 12th 2025
- Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
September 12th 2025
- Latest NIMBLE Study Results Highlight Progress in gMG Research
September 12th 2025
- ACT Brief Episode 8: Expert Insights on the Future of Obesity Drug Trials
September 11th 2025
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
FDA Fast Tracks Sanofi’s Intravitreal Gene Therapy for Neovascular Age-Related Macular Degeneration
2
Vabysmo Shows Long-Term Efficacy and Safety in Wet AMD, PCV Patients
3
Q&A: Strategies for Successful Global Clinical Trial Delivery
4
Trial Data Leads to NCCN Recommendation for Modeyso in Recurrent High Grade Glioma Patients
5